$2.39
4.82% day before yesterday
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US0053291078
Symbol
ADAG

Adagene Inc - ADR Stock price

$2.39
+0.52 27.81% 1M
+0.41 20.71% 6M
+0.40 20.10% YTD
-0.32 11.81% 1Y
+1.04 77.04% 3Y
-27.60 92.03% 5Y
-27.60 92.03% 10Y
-27.60 92.03% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.11 4.82%
ISIN
US0053291078
Symbol
ADAG
Industry

Key metrics

Basic
Market capitalization
$107.5m
Enterprise Value
$40.5m
Net debt
positive
Cash
$85.2m
Shares outstanding
58.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1,074.6 | 11.1
EV/Sales
404.8 | 4.2
EV/FCF
negative
P/B
2.1
Financial Health
Equity Ratio
56.6%
Return on Equity
-66.2%
ROCE
-70.4%
ROIC
269.0%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$100.0k | $9.7m
EBITDA
$-35.2m | $-34.4m
EBIT
$-36.0m | $-37.3m
Net Income
$-33.4m | $-41.7m
Free Cash Flow
$-29.7m
Growth (TTM | estimate)
Revenue
-99.5% | 9,590.0%
EBITDA
- | 2.2%
EBIT
-51.6% | -3.7%
Net Income
-76.4% | -24.6%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
-34,136.2% | -355.4%
EBIT
-34,836.8%
Net
-32,387.7% | -429.8%
Free Cash Flow
-28,812.6%
More
EPS
$-0.6
FCF per Share
$-0.5
Short interest
0.2%
Employees
138
Rev per Employee
$0.0
Show more

Is Adagene Inc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Adagene Inc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Adagene Inc - ADR forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Adagene Inc - ADR forecast:

Buy
70%
Hold
30%

Financial data from Adagene Inc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
0.10 0.10
99% 99%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 7.27 7.27
16% 16%
7,270%
- Research and Development Expense 29 29
21% 21%
28,780%
-35 -35
-
-35,230%
- Depreciation and Amortization 0.72 0.72
-
720%
EBIT (Operating Income) EBIT -36 -36
52% 52%
-35,952%
Net Profit -33 -33
76% 76%
-33,420%

In millions USD.

Don't miss a Thing! We will send you all news about Adagene Inc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Adagene Inc - ADR Stock News

Neutral
GlobeNewsWire
12 days ago
Muzastotug (ADG126) Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached
Neutral
GlobeNewsWire
about one month ago
- Alignment gained on Phase 2 inclusion/exclusion criteria, primary and secondary endpoints, and study design, including sample size and dosing regimen
Neutral
GlobeNewsWire
about 2 months ago
Adagene to provide proprietary antibody to ConjugateBio for development as novel bispecific ADCs SAN DIEGO and SUZHOU, China and PRINCETON, N.J., July 08, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced a partnership with ConjugateBio Inc. (ConjugateBio) to provide a proprie...
More Adagene Inc - ADR News

Company Profile

Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Head office Cayman Islands
CEO Peizhi Luo
Employees 138
Founded 2011
Website www.adagene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today